According to recent published studies conducted by the (FDA) Food and Drug Administration and the British Medical Journal have shed light onto the ever increasing incidences of bone fractures and hip fractures amongst individuals who have been prescribed acid reflux medication containing proton pump inhibitors. The increasing use of proton pump inhibiter medication for the treatment of gastrointestinal diagnosis including acid reflux disease and heart burn is correlated with an increasing rise in patients sustaining bone fractures in the hips, the wrists, and hands, the foot and spine fractures. A list of the most popular antacid medication containing proton pump inhibitors include
FDA Consumer Warning on Antacid Medication and Bone Fractures:Several consumer updates regarding the risk of bone fractures amongst individuals taking Antacid Medications have been issued by the Food and Drug Administration over the past four years. In light of increasing evidence of a significant risk of bone fractures the FDA issued a Drug Facts labeling change on all medications containing PPI’s to include new safety information about a possible increased risk of fractures of the hip, wrist, and spine with the use of these medications”. According to the FDA the change in policy can about via increasing knowledge of a heightened risk of bone fracture amongst individuals who had, “received high doses of proton pump inhibitors or used them for one year or more.”
Filing a Drug Side Effect Lawsuit Against Pharmaceutical Companies:Generally there are three distinct causes of action which can be used to hold a manufacturer liable in a product liability claim. A knowledgeable plaintiffs attorney will be charged with the duty of analysis the most optimum cause of action. A brief explanation of the three causes of action is provided below.
- Design Defect: A cause of action for a design defect can be proved by showing evidence of the existence of a comparable design which posed a lesser risk of injury than the deign implemented.
- Manufacturing Defect: A manufacturing defect takes place when the final produced good is markedly different and as a result more dangerous than its original intended design.
- Labeling Defect – Failure to Warn: In many instances drug companies fail to place warning signs in the packaging of their products stating the known dangers associated with its use.